Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
ELISA Kit for Anti-Insulin Receptor Antibody (Anti-INSR)
CD220; ISR; HHF5; IR
- Product No.AEA895Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma and other biological fluids
- Test MethodIndirect ELISA
- Assay Length2h, 30min
- Detection Range3.12-200ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 1.24ng/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 588
For more details, please contact local distributors! US$ 840 US$ 3780 US$ 7140 US$ 58800
Specificity
This assay has high sensitivity and excellent specificity for detection of Anti-Insulin Receptor Antibody (Anti-INSR).
No significant cross-reactivity or interference between Anti-Insulin Receptor Antibody (Anti-INSR) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of Anti-Insulin Receptor Antibody (Anti-INSR) and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-Insulin Receptor Antibody (Anti-INSR) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 91-105 | 99 |
EDTA plasma(n=5) | 88-103 | 96 |
heparin plasma(n=5) | 85-99 | 92 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Anti-Insulin Receptor Antibody (Anti-INSR) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Anti-Insulin Receptor Antibody (Anti-INSR) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-Insulin Receptor Antibody (Anti-INSR) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 79-101% | 79-92% | 79-104% | 94-102% |
EDTA plasma(n=5) | 84-98% | 99-105% | 84-103% | 95-104% |
heparin plasma(n=5) | 92-101% | 95-105% | 89-97% | 94-102% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 5 times;
5. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
6. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
IOSR Journal of Applied Chemistry | Molecular and Biochemical Effect of Neem Extract On Experimental Diabetes Org:Source |
Biol Pharm Bull | Age-Dependent Onset of Insulin Resistance in Insulin-Resistant Mice PubMed: 26632184 |
Nanomedicine | A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes pubmed:27623396 |
American Journal of Translational Research | Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3β. pubmed:28337257 |
Biomedicine & Pharmacotherapy | Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylationin diabetic rats. pubmed:27930980 |
Eur Neuropsychopharmacol. | Regulation of insulin receptor phosphorylation in the brains of prenatally stressed rats: New insight into the benefits of antidepressant drug treatment. pubmed:28063625 |
台湾农业研究 | (台灣農業研究67 (4): 355-364) 香菇柄水萃物改善糖尿病降低阿茲海默氏症罹病風險初探 |
Scientific Reports | Mechanism underlying starvation-dependent modulation of olfactory behavior in Drosophila larva Pubmed: 32080342 |
ADVANCED RESEARCHES | Prenatal Stress Induced Spatial Memory Deficit in a Sex-Specific Manner in Mice: Possible Involvement of Hippocampal Insulin Resistance |
Current Biology | Internal State Affects Local Neuron Function in an Early Sensory Processing Center to Shape Olfactory Behavior in Drosophila Larvae |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPA895Hu01 | Recombinant Insulin Receptor (INSR) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA895Hu05 | Recombinant Insulin Receptor (INSR) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA895Hu02 | Recombinant Insulin Receptor (INSR) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA895Hu03 | Recombinant Insulin Receptor (INSR) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA895Hu06 | Recombinant Insulin Receptor (INSR) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA895Hu04 | Recombinant Insulin Receptor (INSR) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA895Hu01 | Polyclonal Antibody to Insulin Receptor (INSR) | WB; IHC; ICC/IF |
PAA895Hu03 | Polyclonal Antibody to Insulin Receptor (INSR) | WB; IHC; ICC; IP. |
PAA895Hu02 | Polyclonal Antibody to Insulin Receptor (INSR) | WB; IHC; ICC; IP. |
LAA895Hu81 | FITC-Linked Polyclonal Antibody to Insulin Receptor (INSR) | WB; IHC; ICC; IF. |
LAA895Hu71 | Biotin-Linked Polyclonal Antibody to Insulin Receptor (INSR) | WB; IHC; ICC. |
MAA895Hu22 | Monoclonal Antibody to Insulin Receptor (INSR) | WB; IF |
MAA895Hu24 | Monoclonal Antibody to Insulin Receptor (INSR) | WB; IHC |
MAA895Hu23 | Monoclonal Antibody to Insulin Receptor (INSR) | WB; IHC; ICC; IP. |
MAA895Hu25 | Monoclonal Antibody to Insulin Receptor (INSR) | WB; IHC; ICC; IP. |
MAA895Hu27 | Monoclonal Antibody to Insulin Receptor (INSR) | WB; IHC; ICC; IP. |
MAA895Hu21 | Monoclonal Antibody to Insulin Receptor (INSR) | WB; IHC; ICC; IP. |
SEA895Hu | ELISA Kit for Insulin Receptor (INSR) | Enzyme-linked immunosorbent assay for Antigen Detection. |
AEA895Hu | ELISA Kit for Anti-Insulin Receptor Antibody (Anti-INSR) | Enzyme-linked immunosorbent assay for Antibody Detection. |
LMA895Hu | Multiplex Assay Kit for Insulin Receptor (INSR) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
KSA895Hu11 | ELISA Kit DIY Materials for Insulin Receptor (INSR) | Main materials for "Do It (ELISA Kit) Yourself". |